21 Rybelsus (oral): No fixed self-pay list price posted Savings program for commercially insured patients can lower cost (e.g., as little as $10/month for 3 mg)
The goal throughout is gradual and sustainable weight management
Combining these therapies is generally safe with medical supervision, making them a promising option for midlife women struggling with hormonal weight gain
doi:10.1016/j.gie.2020.08.023 39Bazerbachi F, Vargas EJ, Rizk M, et al
Disclosures: Phuc Le: Nothing to Disclose, William Herman: Merck Sharp & Dohme: Advisor, Rivus Pharmaceuticals: Advisor, Srinivasan Dasarathy: Nothing to Disclose, Wen Ye: Nothing to Disclose, Victoria Criswell: Nothing to Disclose, Nicole Welch: Nothing to Disclose, Michael Rothberg: Moderna: Stock - publicly traded company 1763 CLINICAL OUTCOMES OF UTILIZING AN INTERACTIVE CARE PLAN (ICP) IN PATIENTS WITH CIRRHOSIS Kathryn Schmidt 1 Jessica Grimm 1 Devin Copley 1 Daniel Penrice 1 Barbara Copeland 1 William Harmsen 1 Rachel Gullerud 1 Winnie Fan 1 Jordan Coffey 1 Julianne Lunde 1 Sarah Harper 1 Hugo Vargas 2 Blanca Lizaola-Mayo 2 Douglas Simonetto 1 , 1 Mayo Clinic Rochester, 2 Mayo Clinic Arizona Background: Patients with cirrhosis face an increased risk of disease-related symptoms and complications, leading to reduced quality of life
The 2024 HSA contribution cap is $4,150 for individual coverage and $8,300 for family coverage